Diagnosis of thanatophoric dysplasia using clinical exome screening

Ceska Gynekol. 2023;88(5):376-379. doi: 10.48095/cccg2023376.

Abstract

Bone dysplasias are a broad, heterogeneous group of diseases. Thanatophoric dysplasia is a rare bone dysplasia, but it is the most common lethal skeletal dysplasias. The major role in diagnostics plays a high-quality ultrasound examination in the 2nd trimester and the latest methods of genetic testing, including clinical exome testing. Knowing the correct diagnosis is crucial for the future of the fetus and the couple.

Keywords: skletal dysplasia; thanaphoric dysplasia; whole exome.

MeSH terms

  • Exome
  • Female
  • Humans
  • Pregnancy
  • Pregnancy Trimester, Second
  • Receptor, Fibroblast Growth Factor, Type 3 / genetics
  • Thanatophoric Dysplasia* / diagnosis
  • Thanatophoric Dysplasia* / genetics
  • Ultrasonography, Prenatal

Substances

  • Receptor, Fibroblast Growth Factor, Type 3

Supplementary concepts

  • Thanatophoric Dysplasia, Type I